Earnings History Data for Sesen Bio, Inc. (SESN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Sesen Bio, Inc.

Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. The company's product portfolio includes Vicinium(TM) which is in its clinical trial, treats high-grade non-muscle invasive bladder cancer. Sesen Bio Inc., formerly known as Eleven Biotherapeutics, is based in Massachusetts, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-02-2023	PM		SESN	Sesen Bio, Inc.	115.47	-0.04	-0.11	0.02	Sesen Bio GAAP EPS of -$0.04 beats by $0.07 [2/28/2023 8:23 AM]	0.5863	0.0 (0.48%)	0.58	-0.01 (-1.17%)	0.37 - 0.96	786,984	970,000	6,307
Sesen Bio GAAP EPS of -$0.04 beats by $0.07 [2/28/2023 8:23 AM]
07-11-2022	PM	8:00 AM ET (Nov 7)	SESN	Sesen Bio	111.00	0.14	-0.08	0.00	Sesen Bio GAAP EPS of $0.10, revenue of $40M [11/7/2022 8:17 AM]	0.5426	0.0 (0.11%)	0.58	0.04 (6.62%)	0.36 - 1.34	1,111,257	640,000	298,731
Sesen Bio GAAP EPS of $0.10, revenue of $40M [11/7/2022 8:17 AM] Sesen Bio Reports Third Quarter 2022 Financial Results and Business Update [Nov-07-22 08:00AM]
28-02-2022	PM		SESN	Sesen Bio	127.00	0.02	-0.08	0.00		0.6481	0.02 (3.12%)	0.65	0.02 (3.25%)	0.56 - 6.04	1,207,213	1,600,000	25,168
Sesen Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Anticipated Regulatory Path Forward for the Companys Lead Product Candidate, Vicineum [Feb-28-22 08:00AM]
10-05-2021	PM	7:00 AM ET (May 10)	SESN	Sesen Bio, Inc.	472.59	-0.35	-0.06	0.31	Sesen Bio EPS misses by $0.27 [5/10/2021 7:34 AM]	2.38	-0.28 (-10.67%)	2.72	0.05 (1.87%)	0.62 - 3.57	6,639,853	6,030,000	64,154
Sesen Bio EPS misses by $0.27 [5/10/2021 7:34 AM] Sesen Bio shares fall after Q1 net loss [5/10/2021 8:29 AM] Sesen Bio, Inc. to Host Earnings Call [May-10-21 06:15AM] Sesen Bio Reports First Quarter 2021 Financial Results and Commercial Launch Readiness Update in the US for Vicineum [May-10-21 07:30AM]
15-03-2021	PM		SESN	Sesen Bio, Inc.	382.81	-0.07	-0.10	-0.08	Sesen Bio EPS in-line [3/15/2021 7:34 AM]	2.84	-0.02 (-0.52%)	2.80	-0.06 (-2.10%)	0.37 - 3.54	4,781,235	4,390,586	340,490
Sesen Bio EPS in-line [3/15/2021 7:34 AM] Sesen Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Significant Regulatory and Commercial Readiness Progress for the Companys Lead Product Candidate Vicineum [Mar-15-21 07:00AM]
09-11-2020	PM		SESN	Sesen Bio, Inc.	136.71	-0.19	-0.09	-0.13	Sesen Bio EPS misses by $0.11 [11/9/2020 7:31 AM]	1.10	0.06 (6.31%)	1.08	0.05 (4.85%)	0.37 - 1.54	1,508,765	1,287,915	71,528